Rahul Gupta bought $1K-$15K of NKE stock

Rahul Gupta, Director, Office of National Drug Control Policy, disclosed a purchase of NIKE, Inc. (NKE) stock worth $1K-$15K in an OGE Form 278-T released Aug 30, 2024.

The trade happened on Jul 1, 2024, 60 days before it was made public.

NKE has moved -50.8% since the trade date, from $76.83 to $37.77 (Nov 12, 2026 close).